ID: uc001ima.2_intron_8_0_chr10_13228281_f.5p
GENE: (9)
chr10:13228231-13228480+


(1)
AGO1.ip 		(1)
AGO2.ip 		(1)
B-CELL 		(2)
BRAIN 		(1)
BREAST 		(32)
CELL-LINE 		(1)
FIBROBLAST 		(2)
HELA 		(1)
LIVER 		(5)
OTHER 		(10)
SKIN 		(1)
TESTES 		(1)
XRN.ip

Sense strand
GTAAAGCCAAGAAGAAGAATGGAGAGCCGTGCACGCAGACTGTGAATTTGGTTGGTTTCAGCCTTGTTAGGATGGTTTCTGCTAAAGAAAAGAACAGTTAGGAATAAACTGTTGGTGCTTTAGCTGTGATGACCAGTTTGGAACTGAGTTTCCCACTTAAAGGAAGAGTCAAAATGAGAAAATTTAATGTGTGGTTAATAACTGCCAGTTTAAAAAAGTGAGGGCAGGGGAAAGGTGAGGGGATTTAACC
........................................................................(((((((.(((((((.....(((((((.......)))))))....)))))))...)).)))))....((((......)))).................................................................................................
...............................................................64.......................................................................................153...............................................................................................
SizePerfect hitTotal NormPerfect NormSRR207116(GSM721078)
Nuclear RNA. (cell line)		SRR037940(GSM510478)
293cand5_rep2. (cell line)		SRR037939(GSM510477)
293cand5_rep1. (cell line)		DRR001489(DRX001043)
"Hela short nuclear cell fraction, control". (hela)		SRR037937(GSM510475)
293cand2. (cell line)		SRR037942(GSM510480)
293DroshaTN_cand5. (cell line)		SRR037944(GSM510482)
293DcrTN_cand5. (cell line)		DRR000557(DRX000315)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		DRR001488(DRX001042)
"Hela short nuclear cell fraction, LNA(+)". (hela)		SRR037935(GSM510473)
293cand3. (cell line)		DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)		SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)		DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)		DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		SRR037938(GSM510476)
293Red. (cell line)		SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)		SRR326282(GSM769512)
"Dicer mRNA was knocked down using siDicer, t. (cell line)		SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)		GSM359208(GSM359208)
hepg2_bindASP_hl_2. (cell line)		SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)		SRR189784SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)		SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)		SRR029130(GSM416759)
DLD2. (cell line)		SRR060168(GSM565978)
5-8F_nucleus. (cell line)		SRR553576(SRX182782)
source: Testis. (testes)		RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)		SRR343334SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)		SRR037936(GSM510474)
293cand1. (cell line)		SRR207110(GSM721072)
Nuclear RNA. (cell line)		SRR029129(GSM416758)
SW480. (cell line)		SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)		GSM359192(GSM359192)
HepG2_3pM_6. (cell line)		GSM416733(GSM416733)
HEK293. (cell line)		SRR390725(GSM850204)
small rna immunoprecipitated. (cell line)		SRR189782SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)		SRR037931(GSM510469)
293GFP. (cell line)		SRR363675(GSM830252)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)		SRR330862(SRX091700)
tissue: skin psoriatic involveddisease state:. (skin)		SRR330870(SRX091708)
tissue: skin psoriatic involveddisease state:. (skin)		SRR330877(SRX091715)
tissue: skin psoriatic involveddisease state:. (skin)		SRR189786SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)		SRR029132(GSM416761)
MB-MDA231. (cell line)		GSM450602(GSM450602)
miRNA sequencing raw reads from post-mortem s. (brain)		SRR037934(GSM510472)
293cand4_rep3. (cell line)		GSM359195(GSM359195)
HepG2_TAP_depl. (cell line)		SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)		DRR000560(DRX000318)
Isolation of RNA following immunoprecipitatio. (ago1 cell line)		SRR330876(SRX091714)
tissue: skin psoriatic involveddisease state:. (skin)		SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)		GSM450598(GSM450598)
miRNA sequencing raw reads from post-mortem s. (brain)		SRR343337
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTGAGT.....................................................................................................281159.00159.0041.0027.0020.0011.009.0011.005.003.004.005.002.00-1.001.002.003.001.003.00-1.00--1.00--2.00---1.00--1.001.00--------1.001.00--------1.00---
........................................................................................................................TAGCTGTGATGACCAGTTTGGAACTGAGT.....................................................................................................29134.0034.001.00--3.001.00--2.00--2.00-2.002.001.00-2.00-3.001.002.00-1.00-2.00-1.00-------1.001.00--1.001.001.001.00---1.00----1.00-----
..........................................................................................................................GCTGTGATGACCAGTTTGGAACTGAGT.....................................................................................................2716.006.00---1.00--5.00-------------------------------------------------
............................................................................................................................TGTGATGACCAGTTTGGAACTGAGT.....................................................................................................2514.004.00----4.00---------------------------------------------------
...................TGGAGAGCCGTGCACGCAGACTGCGA.............................................................................................................................................................................................................263.000.00-----------3.00--------------------------------------------
.........AGAAGAAGAATGGAGAGCCGTGCACG.......................................................................................................................................................................................................................2612.002.00-----------------------2.00--------------------------------
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTGAG......................................................................................................2712.002.001.00-------1.00-----------------------------------------------
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTTAGT.....................................................................................................281.000.00------------------------------1.00-------------------------
........................................................................................................................TAGCTGTGATGACCAGTTTGGAACTGAG......................................................................................................2811.001.00------------1.00-------------------------------------------
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTGAGG.....................................................................................................2811.002.00------1.00-------------------------------------------------
.........................................................................................................AAACTGTTGGTGCTTTAGCTGTGATGACCAG..................................................................................................................3111.001.00-----------1.00--------------------------------------------
......CCAAGAAGAAGAATGTAA..................................................................................................................................................................................................................................181.000.00------------------------------------------------------1.00-
....................................................................AGGATGGTTTCTGCTTACC...................................................................................................................................................................191.000.00-----------------------------------------------------1.00--
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTGAGC.....................................................................................................2811.002.00--1.00-----------------------------------------------------
.......CAAGAAGAAGAATGGATTGA...............................................................................................................................................................................................................................201.000.00-----------------------------------------------1.00--------
........................................................................................................................TAGCTGTGATGACCAGTTTGGAA...........................................................................................................2311.001.00-------------------------------------------------1.00------
.................................................................................................................................TGACCAGTTTGGAACTGAGT.....................................................................................................2011.001.00-------1.00------------------------------------------------
.........................................................................................................................AGCTGTGATGACCAGTTTGGAACTGAGTT....................................................................................................2911.001.00----------------------------------------------1.00---------
.............GAAGAATGGAGAGCCGTGCACGCAGA...................................................................................................................................................................................................................2611.001.00------------------------------------------------1.00-------
............................GTGCACGCAGACTGTGAATTTGGTTGGTTTCA..............................................................................................................................................................................................3211.001.00---------------------------1.00----------------------------
...............AGAATGGAGAGCCGTGCACGCAGACT.................................................................................................................................................................................................................2611.001.00---------------------------------------------------1.00----
.....................................................................................AGAAAAGAACAGTTAG.....................................................................................................................................................1690.110.11--------------------------0.11-----------------------------

Antisense strand
GTAAAGCCAAGAAGAAGAATGGAGAGCCGTGCACGCAGACTGTGAATTTGGTTGGTTTCAGCCTTGTTAGGATGGTTTCTGCTAAAGAAAAGAACAGTTAGGAATAAACTGTTGGTGCTTTAGCTGTGATGACCAGTTTGGAACTGAGTTTCCCACTTAAAGGAAGAGTCAAAATGAGAAAATTTAATGTGTGGTTAATAACTGCCAGTTTAAAAAAGTGAGGGCAGGGGAAAGGTGAGGGGATTTAACC
........................................................................(((((((.(((((((.....(((((((.......)))))))....)))))))...)).)))))....((((......)))).................................................................................................
...............................................................64.......................................................................................153...............................................................................................
SizePerfect hitTotal NormPerfect NormSRR207116(GSM721078)
Nuclear RNA. (cell line)		SRR037940(GSM510478)
293cand5_rep2. (cell line)		SRR037939(GSM510477)
293cand5_rep1. (cell line)		DRR001489(DRX001043)
"Hela short nuclear cell fraction, control". (hela)		SRR037937(GSM510475)
293cand2. (cell line)		SRR037942(GSM510480)
293DroshaTN_cand5. (cell line)		SRR037944(GSM510482)
293DcrTN_cand5. (cell line)		DRR000557(DRX000315)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		DRR001488(DRX001042)
"Hela short nuclear cell fraction, LNA(+)". (hela)		SRR037935(GSM510473)
293cand3. (cell line)		DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)		SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)		DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)		DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)		SRR037938(GSM510476)
293Red. (cell line)		SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)		SRR326282(GSM769512)
"Dicer mRNA was knocked down using siDicer, t. (cell line)		SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)		GSM359208(GSM359208)
hepg2_bindASP_hl_2. (cell line)		SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)		SRR189784SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)		SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)		SRR029130(GSM416759)
DLD2. (cell line)		SRR060168(GSM565978)
5-8F_nucleus. (cell line)		SRR553576(SRX182782)
source: Testis. (testes)		RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)		SRR343334SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)		SRR037936(GSM510474)
293cand1. (cell line)		SRR207110(GSM721072)
Nuclear RNA. (cell line)		SRR029129(GSM416758)
SW480. (cell line)		SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)		GSM359192(GSM359192)
HepG2_3pM_6. (cell line)		GSM416733(GSM416733)
HEK293. (cell line)		SRR390725(GSM850204)
small rna immunoprecipitated. (cell line)		SRR189782SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)		SRR037931(GSM510469)
293GFP. (cell line)		SRR363675(GSM830252)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)		SRR330862(SRX091700)
tissue: skin psoriatic involveddisease state:. (skin)		SRR330870(SRX091708)
tissue: skin psoriatic involveddisease state:. (skin)		SRR330877(SRX091715)
tissue: skin psoriatic involveddisease state:. (skin)		SRR189786SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)		SRR029132(GSM416761)
MB-MDA231. (cell line)		GSM450602(GSM450602)
miRNA sequencing raw reads from post-mortem s. (brain)		SRR037934(GSM510472)
293cand4_rep3. (cell line)		GSM359195(GSM359195)
HepG2_TAP_depl. (cell line)		SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)		DRR000560(DRX000318)
Isolation of RNA following immunoprecipitatio. (ago1 cell line)		SRR330876(SRX091714)
tissue: skin psoriatic involveddisease state:. (skin)		SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)		GSM450598(GSM450598)
miRNA sequencing raw reads from post-mortem s. (brain)		SRR343337
....................................................................................................................................................................................................................AAAAAGTGAGGGCAGACTG................... 192.000.00---------------------2.00----------------------------------
..................................................................................................................................................AGTTTCCCACTTAAAAT....................................................................................... 171.000.00-------------------------------------------------------1.00
......................................................................................................................................................................................................................................AAAGGTGAGGGGATTACCT. 191.000.00----------------------------1.00---------------------------
........................................................................................................TAAACTGTTGGTGCTTTAGTTA............................................................................................................................ 221.000.00--------------------------------------------1.00-----------
...................................................................................AAAGAAAAGAACAGTC....................................................................................................................................................... 161.000.00------------------------------------1.00-------------------
..............................................................................................................................................ACTGAGTTTCCCACTTAAGG........................................................................................ 201.000.00-------------------------------1.00------------------------
..........................................................................................................................GCTGTGATGACCAGTTCCCG............................................................................................................ 201.000.00-------------------------------------1.00------------------